IOVA
IOVA
NASDAQ · Biotechnology

Iovance Biotherapeutics Inc

$3.89
+0.27 (+7.46%)
As of Mar 25, 2:06 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 13 76%
Hold 4 24%
Sell 0 0%
Price Target
Analyst Price Target +1,308.0% upside
Low Target $41.45
Average Target $54.77
High Target $77.23
Current Price $3.89
Current
$3.89
Target
$54.77
$41.45 $54.77 avg $77.23
Scenario Analysis
Bear Case
$41.45
965.6%
Low target
Base Case
$54.77
+1,308.0%
Avg target
Bull Case
$77.23
+1,885.3%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.09
-36.1% from high
52-Week Low
$1.64
+137.4% from low
Target vs 52W High
$54.77
+799.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%